Rajasthan suspends 9 ART, surrogacy registrations of Jaipur hospital over sex-selection ad
Synopsis
Key Takeaways
The Rajasthan government on 25 August 2025 suspended nine registration certificates of Neelkanth Fertility and Women Care Hospital Private Limited, a Jaipur-based private fertility chain, over alleged violations of the Assisted Reproductive Technology (Regulation) Act, 2021. The action — covering ART clinics, an ART bank, and a surrogacy clinic spread across six cities — takes immediate effect and will remain in force until further orders.
What Triggered the Action
The suspension was set in motion after a Jaipur edition of an English-language newspaper carried an advertisement for the hospital's IVF, fertility, and test-tube baby centre depicting a foetus in blue. Rajasthan Principal Secretary (Medical and Health) Gayatri Rathore said the department treated the depiction as a prima facie indication of sex-selection promotion, since the colour blue is conventionally associated with a male child. Sex selection and sex-selective ART procedures are explicitly prohibited under the 2021 Act.
Facilities Suspended Across Six Cities
The nine suspended registrations span facilities in Jaipur, Bhilwara, Udaipur, Kota, Jodhpur, and Ajmer. They include ART Clinic Level-1 facilities in Bhilwara, Kota, Udaipur, Ajmer and Jodhpur; ART Clinic Level-2 facilities in the same five cities; two ART Clinic Level-2 units in Jaipur; one surrogacy clinic in Jaipur; and one ART bank in Jaipur. The breadth of the suspension effectively halts the hospital group's operations across Rajasthan.
What the Government Said
Rajasthan Medical and Health Minister Gajendra Singh Khimsar stated that the state government is ensuring strict compliance with prescribed standards and legal provisions in the delivery of health services. The department reiterated that any direct or indirect promotion of prohibited practices — including sex selection — will not be tolerated under any circumstances. Officials added that stringent action will continue against institutions found to be in violation of statutory provisions.
Regulatory and Ethical Context
The Assisted Reproductive Technology (Regulation) Act, 2021 was enacted to bring India's rapidly growing fertility industry under a structured legal framework, prohibiting sex selection and mandating registration of all ART clinics and banks. This is not the first time a fertility clinic in India has faced regulatory action over advertising that allegedly signals sex preference — a practice that critics argue exploits the country's persistent son-preference bias. Notably, the action comes amid a broader national push to enforce the Act's provisions, which only became fully operational after the corresponding rules were notified.
What Happens Next
The suspensions remain in force until further orders, meaning the hospital group cannot legally offer ART or surrogacy services at any of the nine registered facilities in the interim. The department has not yet indicated whether a show-cause notice has been issued or whether criminal proceedings under the Act are under consideration. The state government said it remains committed to ensuring safe, transparent, and high-quality reproductive healthcare while strengthening compliance across all institutions.